Imugene Limited Share Price
Stocks
IMU
AU000000IMU9
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:20 08/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0420 AUD | +2.44% |
|
0.00% | -88.49% |
| 28/08 | Imugene Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 28/08 | Imugene Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 2.01Cr 1.4Cr 1.25Cr 1.17Cr 1.06Cr 1.99Cr 135.19Cr 14Cr 5.47Cr 69Cr 5.25Cr 5.13Cr 221.03Cr | P/E 2027 * |
-1.34x | P/E 2028 * | -0.84x |
|---|---|---|---|---|---|
| Enterprise Value | 1.13Cr 78.5L 70.14L 65.44L 59.44L 1.12Cr 76Cr 7.86Cr 3.07Cr 39Cr 2.95Cr 2.88Cr 124.16Cr | EV / Sales 2027 * |
-
| EV / Sales 2028 * | - |
| Free-Float |
96.9% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMU | Delayed | |
OTC Markets
| IUGNF | Delayed | |
|
Deutsche Boerse AG
| ILA | Delayed | |
|
Deutsche Boerse AG
| ILA | End-of-day quote | |
|
Börse Stuttgart
| ILA | Delayed |
| 1 day | +2.44% | ||
| 1 month | -38.24% | ||
| 3 months | -60.00% | ||
| 6 months | -71.03% | ||
| Current year | -88.49% |
| 1 week | 0.04 |  | 0.05 |
| 1 month | 0.04 | | 0.07 |
| Current year | 0.04 | | 0.41 |
| 1 year | 0.04 | | 0.46 |
| 3 years | 0.04 | | 5.1 |
| 5 years | 0.04 | | 21.25 |
| 10 years | 0.04 | | 21.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darren Keamy
DFI | Director of Finance/CFO | - | 04/03/2025 |
Ursula McCurry
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
Sharon Yavrom
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hopper
CHM | Chairman | 70 | 31/10/2012 |
Lesley Russell
BRD | Director/Board Member | 66 | 23/04/2019 |
Jakob Dupont
BRD | Director/Board Member | 61 | 07/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/12/25 | Free | Director | 14,706 | 0.0047% | ||
| 19/12/25 | Free | Director | 29,411 | 0.0093% | ||
| 19/12/25 | Exercice | Director | 14,706 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.44% | 0.00% | -89.63% | -97.25% | 1.4Cr | |
| +4.16% | +4.16% | +49.37% | +94.17% | 7.47TCr | |
| -13.50% | -13.88% | +5.47% | +55.20% | 5.87TCr | |
| -1.39% | +1.21% | +4.15% | +32.26% | 4.84TCr | |
| +0.50% | -2.14% | +331.33% | +702.20% | 4.31TCr | |
| -0.72% | -3.99% | +28.50% | +29.94% | 4.25TCr | |
| +0.34% | -0.52% | +6.56% | +109.35% | 4.14TCr | |
| -0.11% | +1.96% | +9.19% | +52.66% | 3.13TCr | |
| -0.50% | -3.10% | -10.19% | -14.35% | 2.39TCr | |
| -3.32% | -10.86% | -37.32% | +316.28% | 2.22TCr | |
| Average | -1.22% | -2.20% | +29.74% | +128.05% | 3.86TCr | |
| Weighted average by Cap. | -1.65% | -1.56% | +49.65% | +145.54% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.38Cr -2.35Cr -2.1Cr -1.96Cr -1.78Cr -3.35Cr -227.58Cr -24Cr -9.21Cr -115.74Cr -8.83Cr -8.64Cr -372.08Cr | -3.11Cr -2.16Cr -1.93Cr -1.8Cr -1.64Cr -3.08Cr -209.23Cr -22Cr -8.46Cr -106.41Cr -8.12Cr -7.94Cr -342.08Cr |
| Net Debt | -88L -61.25L -54.73L -51.06L -46.38L -87.35L -59Cr -6.14Cr -2.4Cr -30Cr -2.3Cr -2.25Cr -97Cr | 85L 59.16L 52.86L 49.32L 44.8L 84.37L 57Cr 5.93Cr 2.32Cr 29Cr 2.22Cr 2.17Cr 94Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | A$0.0420 | +2.44% | 23,15,349 |
| 07/26/07 | A$0.0410 | 0.00% | 42,84,215 |
| 06/26/06 | A$0.0410 | -4.65% | 39,86,611 |
| 05/26/05 | A$0.0430 | +16.22% | 1,95,37,971 |
| 02/26/02 | A$0.0370 | -5.13% | 54,00,451 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMU Stock
Select your edition
All financial news and data tailored to specific country editions
